HEADER HYDROLASE 10-MAY-02 1LQE TITLE CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-TRYPSIN; COMPND 5 EC: 3.4.21.4 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 ORGAN: PANCREAS KEYWDS FACTOR XA INHIBITOR, ENZYME-INHIBITOR COMPLEX, BLOOD COAGULATION KEYWDS 2 FACTOR, SERINE PROTEINASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.A.SCHREUDER,A.LIESUM REVDAT 4 16-OCT-24 1LQE 1 REMARK LINK REVDAT 3 24-FEB-09 1LQE 1 VERSN REVDAT 2 13-JAN-04 1LQE 1 JRNL REVDAT 1 10-MAY-03 1LQE 0 JRNL AUTH H.MATTER,E.DEFOSSA,U.HEINELT,P.M.BLOHM,D.SCHNEIDER, JRNL AUTH 2 A.MUELLER,S.HEROK,H.A.SCHREUDER,A.LIESUM,V.BRACHVOGEL, JRNL AUTH 3 P.LOENZE,A.WALSER,F.AL-OBEIDI,P.WILDGOOSE JRNL TITL DESIGN AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP OF JRNL TITL 2 3-AMIDINOBENZYL-1H-INDOLE-2-CARBOXAMIDES AS POTENT, JRNL TITL 3 NONCHIRAL, AND SELECTIVE INHIBITORS OF BLOOD COAGULATION JRNL TITL 4 FACTOR XA. JRNL REF J.MED.CHEM. V. 45 2749 2002 JRNL REFN ISSN 0022-2623 JRNL PMID 12061878 JRNL DOI 10.1021/JM0111346 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : -3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 14008 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1629 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.590 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 16.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.350 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LQE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016183. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-96 REMARK 200 TEMPERATURE (KELVIN) : 292.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR571 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54128 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : GRAPHITE MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14008 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 60.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09800 REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.26800 REMARK 200 FOR SHELL : 6.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, CACL2, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.45000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.45000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A -4 REMARK 465 ILE A -3 REMARK 465 PHE A -2 REMARK 465 LEU A -1 REMARK 465 ALA A 0 REMARK 465 LEU A 1 REMARK 465 LEU A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 VAL A 6 REMARK 465 ALA A 7 REMARK 465 PHE A 8 REMARK 465 PRO A 9 REMARK 465 VAL A 10 REMARK 465 ASP A 11 REMARK 465 ASP A 12 REMARK 465 ASP A 13 REMARK 465 ASP A 14 REMARK 465 LYS A 15 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 71 -74.47 -126.77 REMARK 500 ASN A 79 -14.01 85.41 REMARK 500 ASN A 115 -163.89 -165.92 REMARK 500 SER A 150 103.74 -162.31 REMARK 500 SER A 195 137.60 -39.44 REMARK 500 SER A 214 -74.12 -115.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 IMA A 250 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 260 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 70 OE1 REMARK 620 2 ASN A 72 O 87.1 REMARK 620 3 VAL A 75 O 159.2 86.7 REMARK 620 4 GLU A 80 OE2 106.4 157.6 86.2 REMARK 620 5 HOH A 283 O 85.5 103.5 76.7 95.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 260 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 270 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMA A 250 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LPG RELATED DB: PDB REMARK 900 1LPG CONTAINS THE CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED REMARK 900 WITH THE SAME INHIBITOR AT 2.0 ANGSTROM REMARK 900 RELATED ID: 1LPK RELATED DB: PDB REMARK 900 1LPK CONTAINS THE CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED REMARK 900 WITH A DIFFERENT INHIBITOR OF THE SAME SERIES AT 2.2 ANGSTROM REMARK 900 RELATED ID: 1LPZ RELATED DB: PDB REMARK 900 1LPZ CONTAINS THE CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED REMARK 900 WITH A DIFFERENT INHIBITOR OF THE SAME SERIES AT 2.4 ANGSTROM REMARK 900 RELATED ID: 1LQD RELATED DB: PDB REMARK 900 1LQD CONTAINS THE CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED REMARK 900 WITH A DIFFERENT INHIBITOR OF THE SAME SERIES AT 2.7 ANGSTROM DBREF 1LQE A -4 245 UNP P00760 TRY1_BOVIN 1 243 SEQRES 1 A 243 PHE ILE PHE LEU ALA LEU LEU GLY ALA ALA VAL ALA PHE SEQRES 2 A 243 PRO VAL ASP ASP ASP ASP LYS ILE VAL GLY GLY TYR THR SEQRES 3 A 243 CYS GLY ALA ASN THR VAL PRO TYR GLN VAL SER LEU ASN SEQRES 4 A 243 SER GLY TYR HIS PHE CYS GLY GLY SER LEU ILE ASN SER SEQRES 5 A 243 GLN TRP VAL VAL SER ALA ALA HIS CYS TYR LYS SER GLY SEQRES 6 A 243 ILE GLN VAL ARG LEU GLY GLU ASP ASN ILE ASN VAL VAL SEQRES 7 A 243 GLU GLY ASN GLU GLN PHE ILE SER ALA SER LYS SER ILE SEQRES 8 A 243 VAL HIS PRO SER TYR ASN SER ASN THR LEU ASN ASN ASP SEQRES 9 A 243 ILE MET LEU ILE LYS LEU LYS SER ALA ALA SER LEU ASN SEQRES 10 A 243 SER ARG VAL ALA SER ILE SER LEU PRO THR SER CYS ALA SEQRES 11 A 243 SER ALA GLY THR GLN CYS LEU ILE SER GLY TRP GLY ASN SEQRES 12 A 243 THR LYS SER SER GLY THR SER TYR PRO ASP VAL LEU LYS SEQRES 13 A 243 CYS LEU LYS ALA PRO ILE LEU SER ASP SER SER CYS LYS SEQRES 14 A 243 SER ALA TYR PRO GLY GLN ILE THR SER ASN MET PHE CYS SEQRES 15 A 243 ALA GLY TYR LEU GLU GLY GLY LYS ASP SER CYS GLN GLY SEQRES 16 A 243 ASP SER GLY GLY PRO VAL VAL CYS SER GLY LYS LEU GLN SEQRES 17 A 243 GLY ILE VAL SER TRP GLY SER GLY CYS ALA GLN LYS ASN SEQRES 18 A 243 LYS PRO GLY VAL TYR THR LYS VAL CYS ASN TYR VAL SER SEQRES 19 A 243 TRP ILE LYS GLN THR ILE ALA SER ASN HET CA A 260 1 HET SO4 A 270 5 HET IMA A 250 33 HETNAM CA CALCIUM ION HETNAM SO4 SULFATE ION HETNAM IMA [4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE- HETNAM 2 IMA 2-CARBONYL]-AMINO}-METHYL)-PHENYL]-TRIMETHYL-AMMONIUM FORMUL 2 CA CA 2+ FORMUL 3 SO4 O4 S 2- FORMUL 4 IMA C34 H36 N5 O2 1+ FORMUL 5 HOH *139(H2 O) HELIX 1 1 ALA A 55 TYR A 59 5 5 HELIX 2 2 SER A 164 TYR A 172 1 9 HELIX 3 3 TYR A 234 SER A 244 1 11 SHEET 1 A 7 TYR A 20 THR A 21 0 SHEET 2 A 7 LYS A 156 PRO A 161 -1 O CYS A 157 N TYR A 20 SHEET 3 A 7 GLN A 135 GLY A 140 -1 N ILE A 138 O LEU A 158 SHEET 4 A 7 PRO A 198 CYS A 201 -1 O VAL A 200 N LEU A 137 SHEET 5 A 7 LYS A 204 TRP A 215 -1 O LYS A 204 N CYS A 201 SHEET 6 A 7 GLY A 226 LYS A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 N PHE A 181 O TYR A 228 SHEET 1 B 7 GLN A 30 ASN A 34 0 SHEET 2 B 7 HIS A 40 ASN A 48 -1 O CYS A 42 N LEU A 33 SHEET 3 B 7 TRP A 51 SER A 54 -1 O VAL A 53 N SER A 45 SHEET 4 B 7 MET A 104 LEU A 108 -1 O MET A 104 N SER A 54 SHEET 5 B 7 GLN A 81 VAL A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 B 7 GLN A 64 LEU A 67 -1 N VAL A 65 O ILE A 83 SHEET 7 B 7 GLN A 30 ASN A 34 -1 N SER A 32 O ARG A 66 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.04 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 128 CYS A 232 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.01 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 LINK OE1 GLU A 70 CA CA A 260 1555 1555 2.37 LINK O ASN A 72 CA CA A 260 1555 1555 2.25 LINK O VAL A 75 CA CA A 260 1555 1555 2.22 LINK OE2 GLU A 80 CA CA A 260 1555 1555 2.48 LINK CA CA A 260 O HOH A 283 1555 1555 2.40 SITE 1 AC1 6 GLU A 70 ASN A 72 VAL A 75 GLU A 77 SITE 2 AC1 6 GLU A 80 HOH A 283 SITE 1 AC2 5 LYS A 169 PRO A 173 GLY A 174 GLN A 240 SITE 2 AC2 5 HOH A 350 SITE 1 AC3 17 ASN A 97 THR A 98 LEU A 99 GLN A 175 SITE 2 AC3 17 ASP A 189 SER A 190 CYS A 191 GLN A 192 SITE 3 AC3 17 SER A 195 TRP A 215 GLY A 216 GLY A 219 SITE 4 AC3 17 CYS A 220 GLY A 226 HOH A 280 HOH A 317 SITE 5 AC3 17 HOH A 388 CRYST1 63.600 63.600 68.900 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015723 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015723 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014514 0.00000